Time course of organ dysfunction in thrombotic microangiopathy patients receiving either plasma perfusion or plasma exchange*
- 1 August 2006
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 34 (8), 2127-2133
- https://doi.org/10.1097/01.ccm.0000227659.14644.3e
Abstract
Few studies have investigated adults with thrombotic microangiopathy (TMA) requiring intensive care unit (ICU) admission, and the treatment remains controversial. To describe causes, outcomes, prognostic factors, and daily organ-failure score changes in adults with TMA requiring ICU admission. A 3-yr single-center cohort study. The patients were 36 adults with TMA admitted to a teaching-hospital medical ICU between January 2000 and June 2003. Of the 36 patients, 22 received plasma infusion and 15 underwent plasma exchange. All patients had anemia and thrombocytopenia at ICU admission, and 13 had neurologic impairment. Median creatinine clearance was 55.2 mL/min (interquartile range, 28.8-75.4). No patient had congenital TMA. Causative factors included microbiologically documented infection in 14 patients, allogeneic transplantation in 7 patients, and concomitant or subsequent systemic disease in 7 patients; 6 patients were human immunodeficiency virus-positive, 5 had drug-induced TMA, 2 were pregnant, and 2 had cancer. In 10 patients, no causative factors were identified. Plasma exchange was associated with a statistically significant decrease in hospital mortality (0 vs. 7 deaths; p < .001). Moreover, daily organ-failure scores were significantly lower in the plasma-exchange group from day 3 to day 9. Patients in the plasma-exchange group received a larger volume of plasma. Plasma exchange may be associated with faster resolution of organ failure and with improved survival for patients with TMA requiring ICU admission.Keywords
This publication has 32 references indexed in Scilit:
- Recent Advances in Thrombotic Thrombocytopenic PurpuraHematology-American Society Hematology Education Program, 2004
- High-Dose Plasma Infusion versus Plasma Exchange as Early Treatment of Thrombotic Thrombocytopenic Purpura/Hemolytic-Uremic SyndromeMedicine, 2003
- Thrombotic MicroangiopathiesNew England Journal of Medicine, 2002
- How I treat patients with thrombotic thrombocytopenic purpura–hemolytic uremic syndromeBlood, 2000
- Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndromeAmerican Journal Of Medicine, 1999
- Therapeutic Plasma Exchange: An Update from the Canadian Apheresis GroupAnnals of Internal Medicine, 1999
- Increasing mortality from thrombotic thrombocytopenic purpura in the United States—analysis of national mortality data, 1968–1991American Journal of Hematology, 1995
- TTP — Desperation, Empiricism, ProgressNew England Journal of Medicine, 1991
- Improved Survival in Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic SyndromeNew England Journal of Medicine, 1991
- Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic PurpuraNew England Journal of Medicine, 1991